Gilles Montalescot heads the Cardiac Care Unit at Pitié-Salpétrière Hospital. He is a practicing Interventional Cardiologist and has extensive experience in basic and clinical research. He is the director of the INSERM research Unit U856 on Thrombosis. His current areas of research include coronary thrombosis from pathogenesis to therapeutics.
Dr Montalescot has been an investigator for many of the new drugs developed in the past fifteen years as well as for many of the new interventional technologies.
Dr. Montalescot is a senior scientist and has been the principal investigator of several national or international randomized trials including the ADMIRAL, ARMADA, ALBION, STEEPLE, ABOARD and ARCHIPELAGO studies .
Dr Montalescot is an active member of several organizations with a major interest in education and research in thromboembolic diseases. He has been the chairman of the working group on Thrombosis of the French Society of Cardiology and a nucleus member of the Working Group on Thrombosis and Platelets of the European Society of Cardiology. He has served on several task force committees on antithrombotic drugs and acute coronary syndromes. Dr Montalescot has received several awards in his country including the J. Valade Prize from the Fondation de France and the J. Escalle award from the National Academy of Medicine. He is a member of the editorial board of the European Heart Journal and has published many peer-reviewed articles in journals such as The NEJM, JAMA, Circulation, ATVB and Circulation Research. He has also been invited to give numerous international lectures.VVV